News on Cladribine from BioPortfolio.com http://www.BioPortfolio.com Consolidated Cladribine news from BioPortfolio.com Tue, 09 Feb 2010 19:08:04 GMT en Hope of new treatment for MS patientshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036667&HITNO=0&MSIZE=177&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cladribine&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036667&THISHREF=http://c.moreover.com/click/here.pl%3fz2536699820%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036667&HITNO=0&MSIZE=177&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cladribine&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036667&THISHREF=http://c.moreover.com/click/here.pl%3fz2536699820%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCalgary Herald: Queen Mary, University of London: Little pill means big news in the treatment of MShttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024505&HITNO=1&MSIZE=177&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cladribine&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024505&THISHREF=http://c.moreover.com/click/here.pl%3fz2528946347%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024505&HITNO=1&MSIZE=177&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cladribine&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024505&THISHREF=http://c.moreover.com/click/here.pl%3fz2528946347%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Promising oral drugs in the pipeline for relapsing'remitting MShttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4022692&HITNO=2&MSIZE=177&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cladribine&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4022692&THISHREF=http://c.moreover.com/click/here.pl%3fz2527805354%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4022692&HITNO=2&MSIZE=177&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cladribine&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4022692&THISHREF=http://c.moreover.com/click/here.pl%3fz2527805354%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacist.com: A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019682&HITNO=3&MSIZE=177&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cladribine&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019682&THISHREF=http://c.moreover.com/click/here.pl%3fz2526437242%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019682&HITNO=3&MSIZE=177&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cladribine&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019682&THISHREF=http://c.moreover.com/click/here.pl%3fz2526437242%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013444&HITNO=4&MSIZE=177&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cladribine&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013444&THISHREF=http://c.moreover.com/click/here.pl%3fz2523721248%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013444&HITNO=4&MSIZE=177&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cladribine&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013444&THISHREF=http://c.moreover.com/click/here.pl%3fz2523721248%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNew England Journal of Medicine: Leukemia Therapy Offers Hope to Multiple Sclerosis Patientshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4001606&HITNO=5&MSIZE=177&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cladribine&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4001606&THISHREF=http://c.moreover.com/click/here.pl%3fz2518507088%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4001606&HITNO=5&MSIZE=177&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cladribine&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4001606&THISHREF=http://c.moreover.com/click/here.pl%3fz2518507088%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAssociated Content: Merck KGaA Still Undecided on Cladribine Timelinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3995052&HITNO=6&MSIZE=177&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cladribine&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3995052&THISHREF=http://c.moreover.com/click/here.pl%3fz2515440225%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3995052&HITNO=6&MSIZE=177&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cladribine&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3995052&THISHREF=http://c.moreover.com/click/here.pl%3fz2515440225%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFDA News: Merck KGaA (MKGAF.PK) Met US Regulators on Cladribine in January But No Timetable on Resubmitting MS Drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3993108&HITNO=7&MSIZE=177&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cladribine&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3993108&THISHREF=http://c.moreover.com/click/here.pl%3fz2514459753%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3993108&HITNO=7&MSIZE=177&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cladribine&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3993108&THISHREF=http://c.moreover.com/click/here.pl%3fz2514459753%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioSpace: Merck KGaA (MKGAF.PK) Met US Regulators on Cladribine in Januaryhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3991873&HITNO=8&MSIZE=177&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cladribine&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3991873&THISHREF=http://c.moreover.com/click/here.pl%3fz2513905687%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3991873&HITNO=8&MSIZE=177&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cladribine&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3991873&THISHREF=http://c.moreover.com/click/here.pl%3fz2513905687%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioSpace: Results from CLARITY study with Cladribine in multiple sclerosishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3984774&HITNO=9&MSIZE=177&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cladribine&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3984774&THISHREF=http://c.moreover.com/click/here.pl%3fz2508339941%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3984774&HITNO=9&MSIZE=177&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cladribine&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3984774&THISHREF=http://c.moreover.com/click/here.pl%3fz2508339941%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIrish Medical News: Despite FDA's Letter to Merck Serono, Oral Cladribine is Still Expected to be the First Oral Disease-Modifyinghttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974344&HITNO=10&MSIZE=177&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cladribine&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974344&THISHREF=http://c.moreover.com/click/here.pl%3fz2503428553%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974344&HITNO=10&MSIZE=177&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cladribine&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974344&THISHREF=http://c.moreover.com/click/here.pl%3fz2503428553%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRehab Manegement: FDA okays oral drug for Multiple Sclerosishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3964842&HITNO=11&MSIZE=177&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cladribine&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3964842&THISHREF=http://c.moreover.com/click/here.pl%3fz2498293218%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3964842&HITNO=11&MSIZE=177&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cladribine&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3964842&THISHREF=http://c.moreover.com/click/here.pl%3fz2498293218%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comExaminer.com: Study: MS pills show promise, riskhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3957718&HITNO=12&MSIZE=177&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cladribine&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3957718&THISHREF=http://c.moreover.com/click/here.pl%3fz2495069272%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3957718&HITNO=12&MSIZE=177&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cladribine&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3957718&THISHREF=http://c.moreover.com/click/here.pl%3fz2495069272%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comLeesburg Daily Commercial: A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3957411&HITNO=13&MSIZE=177&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cladribine&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3957411&THISHREF=http://c.moreover.com/click/here.pl%3fz2494941041%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3957411&HITNO=13&MSIZE=177&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cladribine&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3957411&THISHREF=http://c.moreover.com/click/here.pl%3fz2494941041%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDoctors Guide: Two-Year Results From CLARITY Study with Cladribine Tablets in Multiple Sclerosis Published in The New Englandhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3954195&HITNO=14&MSIZE=177&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cladribine&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3954195&THISHREF=http://c.moreover.com/click/here.pl%3fz2492553828%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3954195&HITNO=14&MSIZE=177&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cladribine&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3954195&THISHREF=http://c.moreover.com/click/here.pl%3fz2492553828%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHealthcare Sales & Marketing Network: